A Systematic Review on Effect of Sodium-Glucose cotransporter-2 inhibitors on the metabolic and endocrinological profile of patients with Polycystic Ovarian Syndrome.
Madhura RoyRizwana ParveenParvej KhanHaya MajidMani PathakRajesh SaxenaNidhi Bharal AgarwalPublished in: Expert opinion on pharmacotherapy (2024)
There is a requirement for large extensive clinical trials to demonstrate the efficacy of SGLT-2 inhibitors in PCOS patients.